282693
(S)-(+)-2-苯甘氨醇
98%, for peptide synthesis
别名:
(S)-2-氨基-2-苯乙醇, L-(+)-α-苯甘氨醇
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
C6H5CH(NH2)CH2OH
化学文摘社编号:
分子量:
137.18
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352209
MDL number:
Beilstein/REAXYS Number:
3196190
产品名称
(S)-(+)-2-苯甘氨醇, 98%
InChI
1S/C8H11NO/c9-8(6-10)7-4-2-1-3-5-7/h1-5,8,10H,6,9H2/t8-/m1/s1
SMILES string
N[C@H](CO)c1ccccc1
InChI key
IJXJGQCXFSSHNL-MRVPVSSYSA-N
assay
98%
form
solid
optical activity
[α]19/D +33°, c = 0.75 in 1 M HCl
optical purity
ee: 99% (GLC)
reaction suitability
reaction type: solution phase peptide synthesis
mp
75-78 °C (lit.)
application(s)
peptide synthesis
Quality Level
Application
用于合成手性、不对称双噁唑啉。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Tetrahedron Asymmetry, 17, 2270-2270 (2006)
Jin Han et al.
European journal of medicinal chemistry, 124, 583-607 (2016-09-12)
The present study describes our continuous effort to develop epidermal growth factor receptor (EGFR) inhibitors based on the 6-aryl-pyrrolo[2,3-d]pyrimidin-4-amine scaffold. The activity-ADME space has been evaluated by synthesizing 43 new structures, including four variations of the 4-amino group and 34
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持